Rebound-associated vertebral fractures after discontinuation of denosumab—from clinic and biomechanics
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rebound-associated vertebral fractures after discontinuation of denosumab—from clinic and biomechanics
Authors
Keywords
Bone antiresorptives, Bone turnover, Denosumab, Microdamage repair, Rebound-associated vertebral fractures
Journal
OSTEOPOROSIS INTERNATIONAL
Volume 27, Issue 5, Pages 1917-1921
Publisher
Springer Nature
Online
2015-12-22
DOI
10.1007/s00198-015-3458-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- American Society of Biomechanics Journal of Biomechanics Award 2013: Cortical bone tissue mechanical quality and biological mechanisms possibly underlying atypical fractures
- (2015) Joseph R. Geissler et al. JOURNAL OF BIOMECHANICS
- Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial
- (2015) Benjamin Z Leder et al. LANCET
- Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial
- (2015) Michael Gnant et al. LANCET
- Structural and Mechanical Repair of Diffuse Damage in Cortical Bone In Vivo
- (2014) Zeynep Seref-Ferlengez et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial
- (2013) Joy N Tsai et al. LANCET
- Microdamage Caused by Fatigue Loading in Human Cancellous Bone: Relationship to Reductions in Bone Biomechanical Performance
- (2013) Floor M. Lambers et al. PLoS One
- Five years of anti-resorptive activity after a single dose of zoledronate — Results from a randomized double-blind placebo-controlled trial
- (2012) Andrew Grey et al. BONE
- Discontinuation of denosumab and associated fracture incidence: Analysis from the Fracture Reduction Evaluation of Denosumab in Osteoporosis Every 6 Months (FREEDOM) Trial
- (2012) Jacques P Brown et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial
- (2012) M. R. McClung et al. OSTEOPOROSIS INTERNATIONAL
- Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women
- (2011) N. Freemantle et al. OSTEOPOROSIS INTERNATIONAL
- Valid μ finite element models of vertebral trabecular bone can be obtained using tissue properties measured with nanoindentation under wet conditions
- (2010) Uwe Wolfram et al. JOURNAL OF BIOMECHANICS
- Cellular mechanisms of bone remodeling
- (2010) Erik Fink Eriksen REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Contribution of Trabecular and Cortical Components to Biomechanical Behavior of Human Vertebrae: An Ex Vivo Study
- (2009) Jean-Paul Roux et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: A randomized blinded phase 2 clinical trial
- (2008) Paul D. Miller et al. BONE
- Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast Cancer
- (2008) Georgiana K. Ellis et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search